Optimization of lipid-lowering therapy in patients after ischemic stroke. Resolution of the Council of Experts

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
I A VozniukA I Ershova

Abstract

Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients. The algorithm presents the steps for sequential administration of statins, ezetimibe, and PCSK9 inhibitors to achieve target levels of low-density lipoprotein cholesterol.

References

Feb 20, 2003·European Heart Journal·P O BonettiA Lerman
Aug 11, 2006·The New England Journal of Medicine·Pierre AmarencoUNKNOWN Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
Jun 9, 2009·Current Atherosclerosis Reports·Kenneth M Welch
Aug 3, 2013·Stroke; a Journal of Cerebral Circulation·Áine MerwickPeter J Kelly
Aug 16, 2016·European Heart Journal·Nick TownsendMelanie Nichols
Jun 10, 2017·Stroke; a Journal of Cerebral Circulation·Alexander C FlintS Claiborne Johnston
Aug 24, 2017·The New England Journal of Medicine·Marc S SabatineTerje R Pedersen
Aug 25, 2017·The New England Journal of Medicine·Rita F Redberg, Vinay Prasad
Jan 13, 2018·Journal of the American College of Cardiology·Sotirios TsimikasLijuan Liu
Sep 11, 2019·European Heart Journal·François MachUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved